A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 9/70 (2006.01) A61K 31/4439 (2006.01)
Patent
CA 2210711
The present invention provides a method for treating Alzheimer's Disease using a xanomeline transdermal formation. The invention provides desired transdermal xanomeline patch formulations.
Le présent brevet divulgue une méthode de traitement de la maladie d'Alzheimer à l'aide d'une formulation transdermique de xanoméline. Les formulations pour les pastilles transdermiques de xanoméline sont mentionnées.
Bymaster Franklin Porter
Horstmann Michael
Shannon Harlan Edgar
Shipley Lisa Ann
Valia Kirti Himatlal
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Transdermal formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1901682